Consequences of Non-Compliance in HLA-B51 Associated Diseases

Disease Consequences and Complications

Non-compliance with treatment in HLA-B51 associated diseases can lead to increased disease activity, organ damage, and significantly reduced quality of life, with potential life-threatening complications in severe cases 1
Non-compliance with immunosuppressive therapy in patients with posterior segment eye disease can lead to progressive vision loss and eventual blindness 1
Untreated or inadequately treated vascular manifestations may result in thrombosis, aneurysm formation, and potential rupture of arterial aneurysms, which can be life-threatening 1, 2
Non-adherence to treatment for neuro-Behçet's can lead to irreversible neurological damage, cognitive impairment, and disability 1
Untreated gastrointestinal lesions may progress to perforation, bleeding, and fistula formation, requiring emergency surgical intervention 1

Patients who do not adhere to prescribed treatments are at increased risk for disease flares, with each flare potentially causing cumulative organ damage 1
Non-compliance may lead physicians to incorrectly assume treatment ineffectiveness rather than recognizing medication non-adherence as the cause of poor disease control 3
This misinterpretation can result in inappropriate intensification of medication regimens, increasing the risk of adverse effects without addressing the underlying compliance issue 3
Lack of understanding about the disease, psychological conditions like depression, hostility toward authority, and negative attitudes toward treatment contribute to non-compliance 4
Continuous education about the disease, treatment goals, and potential consequences of non-adherence is essential to improve compliance 4
Frequent follow-up visits to assess disease activity, treatment response, and address compliance issues can help improve adherence 1
Simplifying treatment regimens, when possible, can improve adherence 4
Proactive management of medication side effects can improve tolerability and reduce non-compliance 3
Monitoring and addressing psychological factors that may contribute to non-compliance is crucial 4

Regular assessment of inflammatory markers to monitor disease activity is recommended 1
Organ-specific monitoring, such as ophthalmologic examinations for ocular involvement, is necessary 1
Prompt recognition of treatment failure, distinguishing between non-compliance and true treatment resistance, is essential 3, 6